PZENA INVESTMENT MANAGEMENT LLC

Position in GSK — GSK plc

CIK 1027796 NEW YORK, NY

Position in GSK

as of Mar 31, 2026 · filed Apr 24, 2026 Compact

Position Value

$1,038,841

+$379,548 QoQ

Shares Held

18,823

+40.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PZENA INVESTMENT MANAGEMENT LLC holds $1,255,344,803 across 6 Drug Manufacturers - General names. GSK ranks #4 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	17,095,731	$1,036,856,084
2	PFE	Pfizer Inc	5,924,892	$166,370,967
3	JNJ	Johnson & Johnson	203,965	$49,857,204
4	GSK	GSK plc This page	18,823	$1,038,841
5	SNY	Sanofi	19,088	$919,659
6	MRK	Merck & Co., Inc.	2,511	$302,048

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,038,841	18,823	+40.0%	Shares	Sole	2026-04-24
2025-12-31	$659,293	13,444	+54.2%	Shares	Sole	2026-02-06
2025-09-30	$376,225	8,717	+16.1%	Shares	Sole	2025-11-07
2025-06-30	$288,384	7,510	—	Shares	Sole	2025-07-25
No filing history on record for this holder in this stock.